The centre’s typical patient composition comprises up to 60% of patients with type 1 diabetes, and the majority of patients with type 2 diabetes is treated with insulin; both patient groups typically live with the condition for many years. The gene discussed is INS; the disease is type 2 diabetes mellitus.